Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib (Q28263625)
Jump to navigation
Jump to search
scientific article
- Dual Kinase Inhibition in the Treatment of Breast Cancer: Initial Experience with the EGFR/ErbB-2 Inhibitor Lapatinib
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib |
scientific article |
|
Statements
Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib (English)
0 references
Dual Kinase Inhibition in the Treatment of Breast Cancer: Initial Experience with the EGFR/ErbB-2 Inhibitor Lapatinib (English)
0 references
2004
0 references
3 June 2004
0 references
9 Suppl 3
0 references
9
0 references
10-5
0 references
10-15
0 references
suppl_3
0 references